Veracyte, Inc. (VCYT)
43.72
+2.26
(+5.44%)
USD |
NASDAQ |
Aug 25, 15:19
Veracyte Max Drawdown (5Y) : 81.19% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 81.19% |
| June 30, 2026 | 81.19% |
| May 31, 2026 | 81.19% |
| April 30, 2026 | 81.19% |
| March 31, 2026 | 81.19% |
| February 28, 2026 | 81.19% |
| January 31, 2026 | 81.19% |
| December 31, 2025 | 81.19% |
| November 30, 2025 | 81.19% |
| October 31, 2025 | 81.19% |
| September 30, 2025 | 81.19% |
| August 31, 2025 | 81.19% |
| July 31, 2025 | 81.19% |
| June 30, 2025 | 81.19% |
| May 31, 2025 | 81.19% |
| April 30, 2025 | 81.19% |
| March 31, 2025 | 81.19% |
| February 28, 2025 | 81.19% |
| January 31, 2025 | 81.19% |
| December 31, 2024 | 81.19% |
| November 30, 2024 | 81.19% |
| October 31, 2024 | 81.19% |
| September 30, 2024 | 81.19% |
| August 31, 2024 | 81.19% |
| July 31, 2024 | 81.19% |
| Date | Value |
|---|---|
| June 30, 2024 | 81.19% |
| May 31, 2024 | 81.19% |
| April 30, 2024 | 81.19% |
| March 31, 2024 | 81.19% |
| February 29, 2024 | 81.19% |
| January 31, 2024 | 81.19% |
| December 31, 2023 | 81.19% |
| November 30, 2023 | 81.19% |
| October 31, 2023 | 81.19% |
| September 30, 2023 | 81.19% |
| August 31, 2023 | 81.19% |
| July 31, 2023 | 81.19% |
| June 30, 2023 | 81.19% |
| May 31, 2023 | 81.19% |
| April 30, 2023 | 81.19% |
| March 31, 2023 | 81.19% |
| February 28, 2023 | 81.19% |
| January 31, 2023 | 81.19% |
| December 31, 2022 | 81.19% |
| November 30, 2022 | 81.19% |
| October 31, 2022 | 81.19% |
| September 30, 2022 | 81.02% |
| August 31, 2022 | 81.02% |
| July 31, 2022 | 81.02% |
| June 30, 2022 | 81.02% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Globus Medical, Inc. | 47.91% |
| Recursion Pharmaceuticals, Inc. | 93.13% |
| Anika Therapeutics, Inc. | 83.15% |
| Perspective Therapeutics, Inc. | 93.08% |
| Teleflex, Inc. | 76.68% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -20.80 |
| Beta (5Y) | 1.947 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 59.92% |
| Historical Sharpe Ratio (5Y) | -0.048 |
| Historical Sortino (5Y) | -0.1045 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 22.75% |